Amadeusz Juskowiak

Fda okays drug to lessen hemophiliacs bleeding

The federal Food and Drug Administration said it approved for US marketing a drug that reduces bleeding in hemophiliacs requiring dental work

The FDA said the drug tranemaxic acid would lessen and in some cases eliminate altogether the need for blood transfusions in hemophiliacs who must have teeth extracted

The drug will be made by Kabivitrum of Stockholm Sweden and distributed here under the trade name Cyklokapron by Kabivitrum Inc of Alameda Calif

Hemophilia is a hereditary diseease whose victims lack the particular proteins that promote blood clotting